Ju‐Ming Wang

1.7k total citations · 1 hit paper
27 papers, 1.4k citations indexed

About

Ju‐Ming Wang is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Ju‐Ming Wang has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Immunology and 9 papers in Oncology. Recurrent topics in Ju‐Ming Wang's work include Biomarkers in Disease Mechanisms (7 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Ju‐Ming Wang is often cited by papers focused on Biomarkers in Disease Mechanisms (7 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Ju‐Ming Wang collaborates with scholars based in Taiwan, United States and Japan. Ju‐Ming Wang's co-authors include Hsin‐Fang Yang‐Yen, Min‐Liang Kuo, Wannhsin Chen, Jyh-Rong Chao, J. J. Yen, Richard Jove, Ravi Kothapalli, James Turkson, Jin Hong Liu and Marc M. Oshiro and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Ju‐Ming Wang

27 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression

2001 505 citations Pearlie K. Epling‐Burnette, Jin Hong Liu et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ju‐Ming Wang Taiwan	16	801	505	410	225	217	27	1.4k
Alex R. D. Delbridge Australia	14	1.2k 1.4×	438 0.9×	290 0.7×	130 0.6×	198 0.9×	17	1.6k
Braden C. McFarland United States	18	577 0.7×	358 0.7×	323 0.8×	153 0.7×	208 1.0×	27	1.2k
Céline Charvet France	18	1.0k 1.3×	443 0.9×	608 1.5×	106 0.5×	167 0.8×	26	1.7k
Jennifer Yeh United States	16	762 1.0×	369 0.7×	219 0.5×	94 0.4×	211 1.0×	34	1.3k
Mirjam T. Epping Netherlands	15	1.3k 1.6×	453 0.9×	383 0.9×	97 0.4×	168 0.8×	16	1.7k
Cheh Peng Lim Singapore	10	635 0.8×	658 1.3×	330 0.8×	155 0.7×	164 0.8×	11	1.3k
Chaehwa Park South Korea	21	582 0.7×	367 0.7×	153 0.4×	213 0.9×	359 1.7×	45	1.1k
Francesco Trapasso Italy	26	1.5k 1.9×	375 0.7×	344 0.8×	132 0.6×	312 1.4×	74	2.0k
Adriana Aguilar‐Mahecha Canada	19	835 1.0×	420 0.8×	213 0.5×	115 0.5×	637 2.9×	43	1.7k
Paul J. Coffer Netherlands	18	1.4k 1.7×	353 0.7×	452 1.1×	156 0.7×	272 1.3×	27	2.1k

Countries citing papers authored by Ju‐Ming Wang

Since Specialization

Citations

This map shows the geographic impact of Ju‐Ming Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Ming Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Ming Wang more than expected).

Fields of papers citing papers by Ju‐Ming Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju‐Ming Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Ming Wang. The network helps show where Ju‐Ming Wang may publish in the future.

Co-authorship network of co-authors of Ju‐Ming Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ju‐Ming Wang. A scholar is included among the top collaborators of Ju‐Ming Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju‐Ming Wang. Ju‐Ming Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ying-Ren, et al.. (2024). Epithelial CEBPD activates fibronectin and enhances macrophage adhesion in renal ischemia-reperfusion injury. Cell Death Discovery. 10(1). 328–328. 5 indexed citations

Hung, Liang‐Yi, et al.. (2024). Inactivation of pentraxin 3 suppresses M2-like macrophage activity and immunosuppression in colon cancer. Journal of Biomedical Science. 31(1). 10–10. 16 indexed citations

Wang, Shao‐Ming, et al.. (2023). Astrocytic Cebpd Regulates Pentraxin 3 Expression to Promote Fibrotic Scar Formation After Spinal Cord Injury. Molecular Neurobiology. 60(4). 2200–2208. 8 indexed citations

Tseng, Chin‐Chung, et al.. (2022). Microfluidic aptasensor POC device for determination of whole blood potassium. Analytica Chimica Acta. 1203. 339722–339722. 26 indexed citations

Li, Chien‐Feng, Yi‐Ting Chen, Yu‐Chih Lo, et al.. (2022). Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple‐negative breast cancers. Clinical and Translational Medicine. 12(1). e724–e724. 24 indexed citations

Wang, Ju‐Ming, et al.. (2022). Pentraxin 3 Facilitates Shrimp-Allergic Responses in IgE-Activated Mast Cells. Journal of Immunology Research. 2022. 1–15. 4 indexed citations

Chen, Chen‐Yang, et al.. (2022). Blockade of the pentraxin 3/CD44 interaction attenuates lung injury‐induced fibrosis. Clinical and Translational Medicine. 12(11). e1099–e1099. 17 indexed citations

Chen, Yanting, Sheng‐Nan Wu, Chia‐Jui Yen, et al.. (2022). Pentraxin 3 regulates tyrosine kinase inhibitor-associated cardiomyocyte contraction and mitochondrial dysfunction via ERK/JNK signalling pathways. Biomedicine & Pharmacotherapy. 157. 113962–113962. 11 indexed citations

Chan, Ti‐Chun, Yi‐Ting Chen, Kien Thiam Tan, et al.. (2021). Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis. SHILAP Revista de lepidopterología. 11(12). e674–e674. 14 indexed citations

10.

Chen, Ruoyu, Chia‐Jui Yen, Ju‐Ming Wang, et al.. (2021). CPAP enhances and maintains chronic inflammation in hepatocytes to promote hepatocarcinogenesis. Cell Death and Disease. 12(11). 983–983. 5 indexed citations

11.

Wang, Wei‐Jan, Fei Zhang, Wan‐Jou Shen, et al.. (2021). MCL1 participates in leptin-promoted mitochondrial fusion and contributes to drug resistance in gallbladder cancer. JCI Insight. 6(15). 23 indexed citations

12.

Chen, Yi‐Ting, et al.. (2019). Hepatoma-derived growth factor supports the antiapoptosis and profibrosis of pancreatic stellate cells. Cancer Letters. 457. 180–190. 19 indexed citations

13.

Chang, Che‐Mai, Jaw‐Yuan Wang, Ming‐Feng Hou, et al.. (2014). Function of DNA methyltransferase 3a in lead (Pb²⁺)‐Induced Cyclooxygenase‐2 gene. Environmental Toxicology. 30(9). 1024–1032. 13 indexed citations

14.

Wu, Po‐Ting, et al.. (2012). Role of Macrophage CCAAT/Enhancer Binding Protein Delta in the Pathogenesis of Rheumatoid Arthritis in Collagen-Induced Arthritic Mice. PLoS ONE. 7(9). e45378–e45378. 50 indexed citations

15.

Chang, Kung‐Chao, Shuting Yang, Yaping Chen, et al.. (2011). Aberrantly expressed AURKC enhances the transformation and tumourigenicity of epithelial cells. The Journal of Pathology. 225(2). 243–254. 39 indexed citations

16.

Li, Chien‐Feng, Chiung‐Yuan Ko, Min‐Hsiung Pan, et al.. (2010). CEBPD Reverses RB/E2F1-Mediated Gene Repression and Participates in HMDB-Induced Apoptosis of Cancer Cells. Clinical Cancer Research. 16(23). 5770–5780. 40 indexed citations

17.

Hour, Tzyh‐Chyuan, Chen‐Kung Chou, Ju‐Ming Wang, et al.. (2010). Transcriptional up-regulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cells. Biochemical Pharmacology. 80(3). 325–334. 60 indexed citations

18.

Ko, Chiung‐Yuan, Yi‐Chao Lee, Esta Sterneck, et al.. (2010). CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells. Neurobiology of Aging. 33(2). 422.e11–422.e25. 69 indexed citations

19.

Lai, Ching‐Shu, Ju‐Ming Wang, Vladimir Badmaev, et al.. (2009). Differential inhibitory effects of inotilone on inflammatory mediators, inducible nitric oxide synthase and cyclooxygenase‐2, in LPS‐stimulated murine macrophage. Molecular Nutrition & Food Research. 53(11). 1386–1395. 16 indexed citations

20.

Epling‐Burnette, Pearlie K., Jin Hong Liu, Robyn Catlett-Falcone, et al.. (2001). Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. Journal of Clinical Investigation. 107(3). 351–362. 505 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact